Altogether, our observation that subjects with chronic coronary syndromes have lower serum SIRT1 levels than control subjects might be related to the notion that chronic myocardial ischemia reduces SIRT1 levels; furthermore, diminished SIRT1 activity in chronic coronary syndromes leads to diminished protection versus the progression of atherosclerosis. This evidence concerns the gene SIRT1 and atherosclerosis.